We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sopheon Plc | LSE:SPE | London | Ordinary Share | GB00BSZM1369 | ORD 20P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 990.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/2/2017 13:26 | Hi Bamboo, your target was apron.486 But higher whit the INVH&S pattern. What is your opinion on that target? Thanks Trinko | trinko | |
02/2/2017 13:24 | janeann, I had to order. [Trust the broker!] Price was okay. | bamboo2 | |
02/2/2017 13:23 | well that was fortuitous bamboo ... they aren't easy to buy at the moment. can sell a load tho! | janeann | |
02/2/2017 13:18 | Re-took my position earlier today as it seems likely the INVH&S pattern I mentioned previously will get confirmed at eod. | bamboo2 | |
02/2/2017 12:40 | well it has a helping hand today - tipped in shares mag as a possible doubler. explains the rise today | janeann | |
01/2/2017 23:09 | Bit of a mid morning shake but great to see a finish above £4. Eagerly awaiting the results, particularly the profit number. If the outlook statement speaks of continued momentum this could fly. | chadders | |
01/2/2017 07:38 | Hi LM, I use the advfn fibs as measures and markers for pattern targets calculated with Bulkowski's stats, rather than as fib extentions. The advfn 'Pro chart' tab that I use doesn't seem to have any other way of making measured marks. I have tried using fib extensions, but it seemed very time consuming to do the maths. Bulkowski's method on the other hand seems reasonably fast and reliable, once the pattern has been identified. | bamboo2 | |
31/1/2017 22:30 | Hi Bamboo - I confess I haven't figured out how to properly use them - will have to watch a couple of tutorials - but for blue skyers Fibonacci Extensions is apparently the way to go.. best efforts here starting at the base of the trend | luckymouse | |
31/1/2017 20:42 | LM, great chart. Mine is starting to get too busy, making it, along with many others, less clear and purposeful. edit, Cleared the chart up a little and have looked at various patterns. I have gone for a target of approx 486 based upon the confirmed LT Rising Wedge. The upper trendline could morph into the neckline of an INVH&S, with a higher target. The Breakaway gap between 335-360 could become a support area. | bamboo2 | |
31/1/2017 13:48 | Smithie- could you bring the shares into your eps estimates and show how it is fully priced comapred to its peer group of software companies (at least the ones which turn a profit). I think yesterday's rise was very moderate. | samsj | |
31/1/2017 12:38 | Weekly view - you will tend to get profit taking at each bag level - but if TSI & MF stay above zero it can keep going | luckymouse | |
31/1/2017 11:18 | A finish above £4 will bode well. Still significant upside in my view Smithie6 but if you're out, good luck to you. | chadders | |
31/1/2017 09:25 | ..arguably fully priced imo.. Noting more shares after conv. of options & loan notes. | smithie6 | |
31/1/2017 08:42 | Making an attempt at 400p... | cfro | |
31/1/2017 08:09 | Bought into these today - technically looking very strong and scoring 98 on Stockopedia!!! | essential | |
30/1/2017 22:24 | trinko, I took profit today as needed cash for a new trade [crpr]. Indicators suggest however this could have further to go, I will post a chart in the next day or so, when I catch up a bit. | bamboo2 | |
30/1/2017 17:33 | Posted a new high today. | cfro | |
30/1/2017 16:45 | how many shares if conv. the loan notes ?? +2.6 M new shares ? and hence the subsequent cap value ?, looks like 15M pnds or so of turnover ...so is cap. value (after conversion) / turnover about 2.5-3 ?? | smithie6 | |
30/1/2017 14:27 | Ah, me topslicing, that's what's moved the share price back up again, you're welcome! I'm going to post this here with a recommendation that you get a subscription to Stockopedia yourself - there's any number of great tips that I've completely failed to capitalise on. And if anyone complains about me pasting it here I'll take it down. Sopheon (LON:SPE) Share price: 380p (+13%) No. shares: 7.4m Market cap: £28m Trading Update Posting this in response to reader request. Great news here: "...a strong performance in the second half of 2016, driven by a large number of license orders in the final quarter, including substantial activity with major enterprise customers. In addition to the effect of the stronger sales performance, the profitability of the business was further enhanced by cost efficiencies over the course of the year, and to a lesser extent by foreign exchange gains linked to the sharp fall in Sterling. As a consequence, the Board expects that reported revenues for the year ended 31 December 2016 will be in line with current market expectations. The Board also expects that, even when excluding the impact of the positive foreign exchange effects, EBITDA will be ahead, and pre-tax profits significantly ahead, of current market expectations." So to be absolutely clear, the good news today is due to margins and not sales. I haven't actually looked at this company before (it's great to engage with other investors, because you can get exposed to a lot more interesting ideas!) Anyway, I see that these shares have "multi-bagged" over the past year, rising from 60p. It's a software business, specialising in "Enterprise Innovation Management". Checking their website, I get the following summary: "Sopheon integrated Enterprise Innovation Performance solutions support everything you need for the entire innovation, new product development (NPD), and innovation governance lifecycle." And on the Introductory page for investors: Sopheon (LSE:SPE) is an international provider of software and services for product life cycle management. Our Accolade® solution supports strategic roadmapping, idea development, product portfolio management and the creation, commercialization and replacement of products. So that's reasonably clear, although without trying some of their software for yourself, or talking to staff, the company will inevitably feel like a black box as an investment. When investing in software, a basic test is the strength of cash flow - does the company generate real earnings, or is it capitalising too many of its expenses? Doing a quick test, I see that SPE capitalised £900k of development costs in H1, and amortised £1 million of intangibles (so that £1 million can be added back to net income, to arrive at operating cash flow). That looks like a fair match, and H1 in the previous year was also a fair match. Checking the final results for 2015, I see a similar positive pattern in terms of the match-up between development costs capitalised and intangibles amortised. So on an initial glance, I'd have good confidence in the earnings here. It ha a huge StockRank of 98, and looks worthy of further investigation. | runthejoules | |
30/1/2017 14:19 | Bruceylegs cannot read in to it what do they say?? Thanks a lot Trinko | trinko | |
30/1/2017 14:07 | Stocko's Small Cap Review takes a quick look at Sophie's earnings and gives them the thumbs up... hxxp://www.stockoped | bruceylegs | |
30/1/2017 12:50 | Bamboo, whats about the gap today?? Thanks | trinko | |
30/1/2017 11:22 | Looking good all and holding firm | jpuff | |
30/1/2017 10:58 | Excellent update, well done SPE 👍 | battlebus2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions